FitProven
Evidence Breakdown
Based on 8 studies
THE BIGGER QUESTION
Whether this one statement holds is settled above. What to actually do about it is a wider question, weighed across every claim that bears on it.
Evidence map
For & against, at a glance
Umbrella Review
Pro
Wiecha S et al. · 2025Sports MedicineUmbrella and mapping review of 29 systematic reviews covering 863 unique RCTs and 24 physiotherapeutic treatments for DOMS. Phototherapy appears among the modalities with significant soreness reduction at later timepoints (72–96 h), with effect sizes across all modalities ranging from g = 0.36 to 1.82. But the headline finding is about the evidence itself: **17 of the 29 systematic reviews were of critically low methodological quality on AMSTAR-2 and only two were rated high quality**, and the authors caution that heterogeneity and weakness of the available evidence limit applicability and generalisability. Read as an appraisal of the field rather than of the light: the effect may be real, but it rests on a base that does not currently support confident recommendations.
0.86
Umbrella and mapping review of 29 systematic reviews covering 863 unique RCTs and 24 physiotherapeutic treatments for DOMS. Phototherapy appears among the modalities with significant soreness reduction at later timepoints (72–96 h), with effect sizes across all modalities ranging from g = 0.36 to 1.82. But the headline finding is about the evidence itself: **17 of the 29 systematic reviews were of critically low methodological quality on AMSTAR-2 and only two were rated high quality**, and the authors caution that heterogeneity and weakness of the available evidence limit applicability and generalisability. Read as an appraisal of the field rather than of the light: the effect may be real, but it rests on a base that does not currently support confident recommendations.
Design Umbrella Review (0.95) × quality 0.90 = impact 0.86
View sourceMeta-Analysis
Pro
Li BM et al. · 2024Lasers in Medical ScienceMeta-analysis of 34 RCTs of pre-exercise photobiomodulation in healthy people. Pooled effects were small-to-moderate and statistically significant: muscle endurance SMD 0.31 (95% CI 0.11–0.51), recovery of muscle strength SMD 0.24 (95% CI 0.10–0.39), and creatine kinase MD −77.56 U/L (95% CI −112.67 to −42.44). Crucially, subgroup analysis found benefits in sedentary individuals and in athletes but **no significant benefit in physically active (recreationally trained) individuals** — the group most likely to buy a device — which is a biologically odd pattern and a hint that the pooled signal is not robust.
0.60
Meta-analysis of 34 RCTs of pre-exercise photobiomodulation in healthy people. Pooled effects were small-to-moderate and statistically significant: muscle endurance SMD 0.31 (95% CI 0.11–0.51), recovery of muscle strength SMD 0.24 (95% CI 0.10–0.39), and creatine kinase MD −77.56 U/L (95% CI −112.67 to −42.44). Crucially, subgroup analysis found benefits in sedentary individuals and in athletes but **no significant benefit in physically active (recreationally trained) individuals** — the group most likely to buy a device — which is a biologically odd pattern and a hint that the pooled signal is not robust.
Design Meta-Analysis (1.0) × quality 0.60 = impact 0.60
View sourceMeta-Analysis
Pro
Luo WT et al. · 2022Sports HealthMeta-analysis of 24 RCTs in athletes, independent of the main PBMT research groups. Low-level laser therapy applied **before** exercise significantly improved lower-limb muscle strength at 24 h, 48 h, 96 h and 8 weeks, and reduced serum creatine kinase, IL-6 and oxidative-stress markers; trends toward more repetitions and better oxygen kinetics did not reach the same confidence. The authors nonetheless concluded that "a definite therapeutic effect of LLLT is yet to be established" and called for large, robustly designed trials — a positive pooled result paired with an explicit refusal to call it settled.
0.55
Meta-analysis of 24 RCTs in athletes, independent of the main PBMT research groups. Low-level laser therapy applied **before** exercise significantly improved lower-limb muscle strength at 24 h, 48 h, 96 h and 8 weeks, and reduced serum creatine kinase, IL-6 and oxidative-stress markers; trends toward more repetitions and better oxygen kinetics did not reach the same confidence. The authors nonetheless concluded that "a definite therapeutic effect of LLLT is yet to be established" and called for large, robustly designed trials — a positive pooled result paired with an explicit refusal to call it settled.
Design Meta-Analysis (1.0) × quality 0.55 = impact 0.55
View sourceSystematic Review
Con
Álvarez-Martínez M & Borden G · 2025Lasers in Medical ScienceSystematic review of **whole-body** photobiomodulation — the beds and full-body panels closest to what consumers actually buy — for exercise performance and recovery. Only five studies with 105 physically active participants exist. None of the five reported any benefit of whole-body PBM on fatigue biomarkers or exercise performance; two reported better subjective sleep quality, higher melatonin and lower nighttime heart rate. The authors conclude whole-body PBM "shows no evidence of benefits for exercise recovery or performance" and ask why the localised application appears to work when the full-body one does not. This is the single most important source for the gap between the trial devices (targeted laser/LED clusters at a specified joule dose) and the consumer panel.
0.50
Systematic review of **whole-body** photobiomodulation — the beds and full-body panels closest to what consumers actually buy — for exercise performance and recovery. Only five studies with 105 physically active participants exist. None of the five reported any benefit of whole-body PBM on fatigue biomarkers or exercise performance; two reported better subjective sleep quality, higher melatonin and lower nighttime heart rate. The authors conclude whole-body PBM "shows no evidence of benefits for exercise recovery or performance" and ask why the localised application appears to work when the full-body one does not. This is the single most important source for the gap between the trial devices (targeted laser/LED clusters at a specified joule dose) and the consumer panel.
Design Systematic Review (0.9) × quality 0.55 = impact 0.50
View sourceUmbrella Review
Pro
Wiecha S et al. · 2025Sports MedicineUmbrella and mapping review of 29 systematic reviews covering 863 unique RCTs and 24 physiotherapeutic treatments for DOMS. Phototherapy appears among the modalities with significant soreness reduction at later timepoints (72–96 h), with effect sizes across all modalities ranging from g = 0.36 to 1.82. But the headline finding is about the evidence itself: **17 of the 29 systematic reviews were of critically low methodological quality on AMSTAR-2 and only two were rated high quality**, and the authors caution that heterogeneity and weakness of the available evidence limit applicability and generalisability. Read as an appraisal of the field rather than of the light: the effect may be real, but it rests on a base that does not currently support confident recommendations.
0.86
Umbrella and mapping review of 29 systematic reviews covering 863 unique RCTs and 24 physiotherapeutic treatments for DOMS. Phototherapy appears among the modalities with significant soreness reduction at later timepoints (72–96 h), with effect sizes across all modalities ranging from g = 0.36 to 1.82. But the headline finding is about the evidence itself: **17 of the 29 systematic reviews were of critically low methodological quality on AMSTAR-2 and only two were rated high quality**, and the authors caution that heterogeneity and weakness of the available evidence limit applicability and generalisability. Read as an appraisal of the field rather than of the light: the effect may be real, but it rests on a base that does not currently support confident recommendations.
Design Umbrella Review (0.95) × quality 0.90 = impact 0.86
View sourceMeta-Analysis
Pro
Li BM et al. · 2024Lasers in Medical ScienceMeta-analysis of 34 RCTs of pre-exercise photobiomodulation in healthy people. Pooled effects were small-to-moderate and statistically significant: muscle endurance SMD 0.31 (95% CI 0.11–0.51), recovery of muscle strength SMD 0.24 (95% CI 0.10–0.39), and creatine kinase MD −77.56 U/L (95% CI −112.67 to −42.44). Crucially, subgroup analysis found benefits in sedentary individuals and in athletes but **no significant benefit in physically active (recreationally trained) individuals** — the group most likely to buy a device — which is a biologically odd pattern and a hint that the pooled signal is not robust.
0.60
Meta-analysis of 34 RCTs of pre-exercise photobiomodulation in healthy people. Pooled effects were small-to-moderate and statistically significant: muscle endurance SMD 0.31 (95% CI 0.11–0.51), recovery of muscle strength SMD 0.24 (95% CI 0.10–0.39), and creatine kinase MD −77.56 U/L (95% CI −112.67 to −42.44). Crucially, subgroup analysis found benefits in sedentary individuals and in athletes but **no significant benefit in physically active (recreationally trained) individuals** — the group most likely to buy a device — which is a biologically odd pattern and a hint that the pooled signal is not robust.
Design Meta-Analysis (1.0) × quality 0.60 = impact 0.60
View sourceMeta-Analysis
Pro
Luo WT et al. · 2022Sports HealthMeta-analysis of 24 RCTs in athletes, independent of the main PBMT research groups. Low-level laser therapy applied **before** exercise significantly improved lower-limb muscle strength at 24 h, 48 h, 96 h and 8 weeks, and reduced serum creatine kinase, IL-6 and oxidative-stress markers; trends toward more repetitions and better oxygen kinetics did not reach the same confidence. The authors nonetheless concluded that "a definite therapeutic effect of LLLT is yet to be established" and called for large, robustly designed trials — a positive pooled result paired with an explicit refusal to call it settled.
0.55
Meta-analysis of 24 RCTs in athletes, independent of the main PBMT research groups. Low-level laser therapy applied **before** exercise significantly improved lower-limb muscle strength at 24 h, 48 h, 96 h and 8 weeks, and reduced serum creatine kinase, IL-6 and oxidative-stress markers; trends toward more repetitions and better oxygen kinetics did not reach the same confidence. The authors nonetheless concluded that "a definite therapeutic effect of LLLT is yet to be established" and called for large, robustly designed trials — a positive pooled result paired with an explicit refusal to call it settled.
Design Meta-Analysis (1.0) × quality 0.55 = impact 0.55
View sourceSystematic Review
Con
Álvarez-Martínez M & Borden G · 2025Lasers in Medical ScienceSystematic review of **whole-body** photobiomodulation — the beds and full-body panels closest to what consumers actually buy — for exercise performance and recovery. Only five studies with 105 physically active participants exist. None of the five reported any benefit of whole-body PBM on fatigue biomarkers or exercise performance; two reported better subjective sleep quality, higher melatonin and lower nighttime heart rate. The authors conclude whole-body PBM "shows no evidence of benefits for exercise recovery or performance" and ask why the localised application appears to work when the full-body one does not. This is the single most important source for the gap between the trial devices (targeted laser/LED clusters at a specified joule dose) and the consumer panel.
0.50
Systematic review of **whole-body** photobiomodulation — the beds and full-body panels closest to what consumers actually buy — for exercise performance and recovery. Only five studies with 105 physically active participants exist. None of the five reported any benefit of whole-body PBM on fatigue biomarkers or exercise performance; two reported better subjective sleep quality, higher melatonin and lower nighttime heart rate. The authors conclude whole-body PBM "shows no evidence of benefits for exercise recovery or performance" and ask why the localised application appears to work when the full-body one does not. This is the single most important source for the gap between the trial devices (targeted laser/LED clusters at a specified joule dose) and the consumer panel.
Design Systematic Review (0.9) × quality 0.55 = impact 0.50
View sourceShowing the 4 strongest of 8 studies. Tap any node to expand its detail.
Evidence
PRO (4)
PRO Umbrella Review0.90 Wiecha S, Cieśliński I et al. (2025)
Phototherapy appears among the modalities significantly reducing soreness at 72-96 h; effect sizes across all 24 modalities range g = 0.36 to 1.82
Umbrella and mapping review of 29 systematic reviews covering 863 unique RCTs and 24 physiotherapeutic treatments for DOMS. Phototherapy appears among the modalities with significant soreness reduction at later timepoints (72–96 h), with effect sizes across all modalities ranging from g = 0.36 to 1.82. But the headline finding is about the evidence itself: 17 of the 29 systematic reviews were of critically low methodological quality on AMSTAR-2 and only two were rated high quality, and the authors caution that heterogeneity and weakness of the available evidence limit applicability and generalisability. Read as an appraisal of the field rather than of the light: the effect may be real, but it rests on a base that does not currently support confident recommendations.
Weighted 0.90 — k=29 systematic reviews covering 863 unique RCTs; no pooled participant total is reported, so sample size is omitted. Publicly funded and methodologically careful — it applies AMSTAR-2 to its own inputs and reports that 17 of the 29 reviews are critically low quality and only two are high. Its ceiling is the evidence beneath it, not the review itself.
Funding: Ministry of Education and Science, Poland / Jozef Pilsudski University of Physical Education in Warsaw (grant 2/BN/UPB/2023)
Sports Medicine
PRO Meta-Analysis0.60 Li BM, Qiu DY et al. (2024)
Pre-exercise photobiomodulation produced small pooled benefits -- muscle endurance SMD 0.31 (95% CI 0.11-0.51), strength recovery SMD 0.24 (0.10-0.39) and creatine kinase MD -77.56 U/L (-112.67 to -42.44) -- but no significant benefit in physically active individuals
Meta-analysis of 34 RCTs of pre-exercise photobiomodulation in healthy people. Pooled effects were small-to-moderate and statistically significant: muscle endurance SMD 0.31 (95% CI 0.11–0.51), recovery of muscle strength SMD 0.24 (95% CI 0.10–0.39), and creatine kinase MD −77.56 U/L (95% CI −112.67 to −42.44). Crucially, subgroup analysis found benefits in sedentary individuals and in athletes but no significant benefit in physically active (recreationally trained) individuals — the group most likely to buy a device — which is a biologically odd pattern and a hint that the pooled signal is not robust.
Weighted 0.60 — 34 RCTs, but no pooled participant total is stated in any accessible part of the paper, so sample_size is omitted and the precision behind the pooled estimates cannot be independently checked. The article is paywalled and no conflict-of-interest statement could be retrieved; the funder is taken from publisher-asserted Crossref metadata rather than from the article text. Effects are small (SMD 0.24-0.31), and the subgroup pattern is biologically incoherent -- benefit in sedentary people and in athletes but none in the recreationally trained group between them -- which is the signature of small-study effects rather than a real dose-response. The underlying trial literature is dominated by investigators with device-manufacturer ties.
Funding: National Natural Science Foundation of China (31971099, 31500961)
Lasers in Medical Science
PRO Meta-Analysis0.55 Luo WT, Lee CJ et al. (2022)
pre-exercise low-level laser therapy improved lower-limb strength at 24 h, 48 h, 96 h and 8 weeks and reduced creatine kinase, IL-6 and oxidative-stress markers
Meta-analysis of 24 RCTs in athletes, independent of the main PBMT research groups. Low-level laser therapy applied before exercise significantly improved lower-limb muscle strength at 24 h, 48 h, 96 h and 8 weeks, and reduced serum creatine kinase, IL-6 and oxidative-stress markers; trends toward more repetitions and better oxygen kinetics did not reach the same confidence. The authors nonetheless concluded that "a definite therapeutic effect of LLLT is yet to be established" and called for large, robustly designed trials — a positive pooled result paired with an explicit refusal to call it settled.
Weighted 0.55 — k=24 trials, but the paper reports no pooled participant total — only individual trial sizes ranging from 6 to 40, so sample_size is omitted rather than guessed. Cochrane RoB: 14 trials low risk, 10 at higher risk (unclear allocation concealment, short crossover washouts, missing outcome data); laser dosing was heterogeneous and only 3 trials included female athletes. The authors' own verdict is that a definite therapeutic effect of LLLT is yet to be established. No funding statement appears anywhere in the article, so independence could not be verified.
Sports Health
PRO Meta-Analysisn=861CONFLICTED0.40 Vanin AA, Verhagen E et al. (2018)
Favourable pooled effects on time to exhaustion, repetitions, isometric peak torque and blood lactate; parameter window 655-950 nm, 20-60 J for small muscle groups and 60-300 J for large
Systematic review and meta-analysis of 39 randomised trials (861 participants; 28 pooled) of photobiomodulation applied to muscle in healthy people. It reported favourable effects on time to exhaustion, repetitions, isometric peak torque and blood lactate, and derived the parameter window most often used in positive trials: 655–950 nm, 20–60 J for small muscle groups and 60–300 J for large ones, up to 200 mW per diode. The authors themselves graded the evidence "very low to moderate quality", citing poor methodological quality, small samples and wide variation in protocols — and the senior author (Leal-Junior) discloses research support from a laser device manufacturer, so this positive pooled estimate is not independent of the field's dominant research group.
Weighted 0.40 — 39 trials, 861 participants (28 pooled). The authors themselves grade the evidence "very low to moderate quality", citing poor methodological quality, small samples and wide protocol heterogeneity. Independence is the deeper problem: this is a positive pooled estimate whose senior author is funded by a laser manufacturer and whose included trials come substantially from his own group. Heavily downgraded on both precision and independence.
Funding: FAPESP and CNPq (public, Brazil); senior author Leal-Junior discloses research support from Multi Radiance Medical, a laser device manufacturer — the funder profits from this result.
Lasers in Medical Science
AGAINST (3)
AGAINST Systematic Reviewn=1050.55 Álvarez-Martínez M, Borden G (2025)
None of the 5 whole-body photobiomodulation studies (105 physically active participants) found any benefit on fatigue biomarkers or exercise performance; 2 reported better subjective sleep quality, higher melatonin and lower nighttime heart rate
Systematic review of whole-body photobiomodulation — the beds and full-body panels closest to what consumers actually buy — for exercise performance and recovery. Only five studies with 105 physically active participants exist. None of the five reported any benefit of whole-body PBM on fatigue biomarkers or exercise performance; two reported better subjective sleep quality, higher melatonin and lower nighttime heart rate. The authors conclude whole-body PBM "shows no evidence of benefits for exercise recovery or performance" and ask why the localised application appears to work when the full-body one does not. This is the single most important source for the gap between the trial devices (targeted laser/LED clusters at a specified joule dose) and the consumer panel.
Weighted 0.55 — k=5 studies, 105 participants pooled — the entire whole-body PBM literature, so the review is exhaustive and directly on point for the consumer device, and the authors declared no external funding. But the underlying evidence base is tiny and heterogeneous and there is no meta-analysis, so the design class (systematic_review) overstates its precision; 0.55 corrects for that.
Funding: none declared
Lasers in Medical Science
AGAINST RCTn=360.50 Malta ES, de Lira FS et al. (2019)
photobiomodulation had no effect on creatine kinase, LDH, IL-10, TNF-alpha, muscle soreness or countermovement-jump performance vs placebo, and was no different from cold-water immersion or active recovery
Two-part trial in physically active men after high-intensity interval exercise: Part I was double-blind and placebo-controlled (n = 12), Part II compared LED photobiomodulation against cold-water immersion (10 °C, 10 min) and active recovery (n = 36). The LED dose was substantial and within the recommended window — 660–850 nm, 600 J total (300 J per leg across five sites). Photobiomodulation had no effect on creatine kinase, lactate dehydrogenase, IL-10, TNF-α, muscle soreness or countermovement-jump performance versus placebo, and produced outcomes no different from cold-water immersion or active recovery. A well-dosed, properly blinded null result.
Weighted 0.50 — 36 participants in total — Part I was placebo-controlled with n=12, Part II compared three groups of 12 — so every comparison rests on about a dozen people, which makes this an underpowered null rather than a decisive one. What keeps the weight mid-range is that the dose was substantial and within the recommended window, Part I was properly double-blind, and the study is publicly funded (FAPESP) with no commercial relationships declared: an independent null on a commercially promoted device. The authors note no muscle biopsies were taken.
Funding: Sao Paulo Research Foundation (FAPESP)
Frontiers in Physiology
AGAINST Crossover Trialn=130.45 Azuma RHE, Merlo JK et al. (2021)
No difference between active 808 nm laser (28 J per arm) and placebo for repetitions to failure, rating of perceived exertion, or delayed-onset muscle soreness tracked to 72 h post-exercise
Randomised, double-blind, placebo-controlled crossover trial in 13 untrained young women (mean age 20.1), with a 7-day washout. Active laser (808 nm, 100 mW, 28 J per arm) or placebo was applied to the biceps 20 minutes before six sets to failure at 60% of 1RM. There were no statistical differences between active and placebo for repetitions to failure, rating of perceived exertion, or delayed-onset muscle soreness tracked to 72 h post-exercise. The authors declare no commercial relationships — a null result from a group with no device-industry ties, using a dose in the range the field recommends for a small muscle group.
Weighted 0.45 — n=13 untrained young women, randomised double-blind crossover with a 7-day washout and a dose in the range the field recommends for a small muscle group. Independent — university-funded, and the authors state the research was conducted with no commercial or financial relationships. The problem is power: n=13 in a single small muscle group makes this null hard to distinguish from an underpowered miss, so the crossover base weight is cut roughly in half.
Funding: Universidade Norte do Paraná (University of Northern Paraná), protocol 2018-0168
Frontiers in Physiology
NEUTRAL (1)
NEUTRAL Narrative Review0.25 Leal-Junior ECP, Lopes-Martins RAB et al. (2019)
Recommends 640-950 nm at 20-60 J for small muscle groups and 120-300 J for large ones, applied to the skin over the target muscle 5 minutes to 6 hours before activity
Masterclass/recommendations paper from the field's leading group, useful mainly for pinning down what the trials actually do: 640–950 nm, 20–60 J for small muscle groups and 120–300 J for large ones, applied directly to the skin over the target muscle, 5 minutes to 6 hours before activity (endurance protocols also dose immediately after). It carries the disclosure that matters for reading this whole literature: "Professor Ernesto Cesar Pinto Leal-Junior receives research support from Multi Radiance Medical (Solon, OH), a laser device manufacturer." A large share of the positive trials and the pooled analyses built on them come from investigators with this tie.
Weighted 0.25 — A masterclass/recommendations paper, not a study -- no data, no systematic search, no sample -- so it carries no independent evidential weight and is cited only to pin down what the trials actually do. The disclosed tie to a laser device manufacturer (Multi Radiance Medical) is the central caveat for reading this entire literature, because a large share of the positive trials and the pooled analyses built on them come from investigators carrying the same tie. Recorded as an industry-linked source arguing in favour of the sponsor's product category.
Funding: no funding statement; lead author discloses research support from Multi Radiance Medical, a laser device manufacturer
Brazilian Journal of Physical Therapy